Immunohistochemical/JJ
study/NN
of/IN
c-fos-positive/JJ
lymphocytes/NNS
infiltrated/VBN
into/IN
human/JJ
squamous/JJ
cell/NN
carcinomas/NNS
of/IN
the/DT
head/NN
and/CC
neck/NN
during/IN
radiation/NN
therapy/NN
and/CC
its/PRP$
clinical/JJ
significance/NN
./.

C-fos/NN
has/VBZ
been/VBN
reported/VBN
to/TO
be/VB
one/CD
of/IN
the/DT
immediate/JJ
early/JJ
genes/NNS
in/IN
signal/NN
transduction/NN
systems/NNS
after/IN
many/JJ
kinds/NNS
of/IN
stresses/NNS
,/,
including/VBG
ionizing/VBG
radiation/NN
./.
=====
Changes/NNS
in/IN
c-fos/NN
expression/NN
induced/VBN
by/IN
radiation/NN
therapy/NN
in/IN
tumor/NN
tissues/NNS
have/VBP
not/RB
yet/RB
been/VBN
reported/VBN
./.
=====
In/IN
this/DT
study/NN
,/,
we/PRP
have/VBP
attempted/VBN
to/TO
determine/VB
whether/IN
c-fos/NN
expression/NN
is/VBZ
induced/VBN
by/IN
radiotherapy/NN
in/IN
human/JJ
squamous/JJ
cell/NN
carcinomas/NNS
of/IN
the/DT
head/NN
and/CC
neck/NN
and/CC
to/TO
establish/VB
a/DT
possible/JJ
correlation/NN
between/IN
c-fos/NN
expression/NN
and/CC
the/DT
therapeutic/JJ
effects/NNS
of/IN
radiation/NN
therapy/NN
./.
=====
Twenty-seven/CD
patients/NNS
with/IN
tumors/NNS
of/IN
the/DT
oral/JJ
cavity/NN
,/,
oropharynx/NN
,/,
and/CC
maxillary/JJ
sinus/NN
were/VBD
examined/VBN
,/,
all/DT
of/IN
which/WDT
were/VBD
confirmed/VBN
as/IN
squamous/JJ
cell/NN
carcinomas/NNS
./.
=====
After/IN
obtaining/VBG
the/DT
patients/NNS
'/POS
informed/VBN
consent/NN
,/,
biopsies/NNS
were/VBD
performed/VBN
before/IN
treatment/NN
and/CC
at/IN
doses/NNS
of/IN
4/CD
,/,
10/CD
,/,
and/CC
20/CD
Gy/NN
of/IN
radiotherapy/NN
,/,
and/CC
the/DT
specimens/NNS
were/VBD
preserved/VBN
in/IN
liquid/JJ
nitrogen/NN
for/IN
further/JJ
examination/NN
./.
=====
Serial/JJ
sectioning/NN
of/IN
6/CD
micrometer/NN
was/VBD
performed/VBN
using/VBG
a/DT
cryostat/NN
,/,
and/CC
samples/NNS
were/VBD
immunohistochemically/RB
stained/VBN
using/VBG
the/DT
streptoavidin-biotin/JJ
peroxidase/NN
method/NN
and/CC
a/DT
monoclonal/JJ
antibody/NN
against/IN
c-fos/NN
./.
=====
Three/CD
of/IN
the/DT
27/CD
patients/NNS
with/IN
squamous/JJ
cell/NN
carcinoma/NN
showed/VBD
slight/JJ
expression/NN
of/IN
c-fos/NN
in/IN
their/PRP$
tumor/NN
cells/NNS
before/IN
and/or/CC
at/IN
4/CD
or/CC
10/CD
Gy/NN
of/IN
radiotherapy/NN
./.
=====
The/DT
tumors/NNS
showed/VBD
high/JJ
radiosensitivity/NN
./.
=====
Concerning/VBG
tumor-infiltrating/JJ
lymphocytes/NNS
,/,
the/DT
rate/NN
of/IN
moderate/JJ
or/CC
remarkable/JJ
grades/NNS
of/IN
c-fos-positive/JJ
lymphocytes/NNS
before/IN
radiotherapy/NN
and/CC
at/IN
radiation/NN
doses/NNS
of/IN
4/CD
,/,
10/CD
,/,
and/CC
20/CD
Gy/NN
was/VBD
8.0/CD
,/,
29.2/CD
,/,
4.8/CD
,/,
and/CC
0/CD
%/NN
,/,
respectively/RB
./.
=====
The/DT
relationship/NN
between/IN
the/DT
immunohistochemical/JJ
findings/NNS
and/CC
the/DT
antitumor/NN
effect/NN
at/IN
a/DT
radiation/NN
dose/NN
of/IN
20/CD
Gy/NN
was/VBD
examined/VBN
on/IN
the/DT
corresponding/JJ
H/NN
&/CC
E-stained/JJ
sections/NNS
./.
=====
In/IN
patients/NNS
whose/WP$
infiltration/NN
of/IN
c-fos-positive/JJ
lymphocytes/NNS
into/IN
tumor/NN
tissues/NNS
were/VBD
moderate/JJ
or/CC
remarkable/JJ
at/IN
4/CD
Gy/NN
of/IN
radiotherapy/NN
,/,
the/DT
tumors/NNS
responded/VBD
significantly/RB
well/RB
to/TO
radiation/NN
therapy/NN
(/(
P/NN
</JJR
0.025/CD
,/,
chi2/NN
test/NN
)/)
,/,
and/CC
the/DT
patients/NNS
took/VBD
a/DT
significantly/RB
favorable/JJ
clinical/JJ
course/NN
(/(
P/NN
</JJR
0.05/CD
,/,
chi2/NN
test/NN
)/)
./.
=====
In/IN
a/DT
sample/NN
from/IN
one/CD
of/IN
the/DT
patients/NNS
,/,
c-fos-positive/JJ
lymphocytes/NNS
were/VBD
identified/VBN
as/IN
CD4/NN
positive/JJ
and/CC
CD8/NN
negative/JJ
./.
=====
Therefore/RB
,/,
the/DT
high/JJ
radiosensitivity/NN
of/IN
squamous/JJ
cell/NN
carcinomas/NNS
in/IN
our/PRP$
samples/NNS
could/MD
be/VB
explained/VBN
by/IN
an/DT
overexpression/NN
of/IN
c-fos/NN
in/IN
the/DT
tumor-infiltrating/JJ
lymphocytes/NNS
induced/VBN
by/IN
small/JJ
doses/NNS
of/IN
radiation/NN
therapy/NN
,/,
and/CC
these/DT
activated/VBN
lymphocytes/NNS
exerted/VBD
a/DT
cytotoxic/JJ
effect/NN
against/IN
the/DT
cancer/NN
cells/NNS
./.